-transparent.png){kind=logo}
Iron dextran was introduced more than 30 yr ago for the parenteral treatment of iron deficiency anemia that is refractory to oral therapy. Iron dextran is a preparation of ferric hydroxide complexed with a low molecular weight fraction of dextran. Iron deficiency anemia is one of the most common nutritional deficiency diseases and occurs worldwide secondary to inadequate dietary iron, usually with excessive gastrointestinal blood losses. Repletion of iron stores is often complicated by intolerance to oral iron supplementation and may require parenteral iron. Parenteral iron can be administered via the intramuscular or intravenous route either directly or as an additive to total parenteral nutrition. Both routes of administration can cause various side effects and a test dose is recommended before therapeutic administration to assess the risk for anaphylaxis. Although the efficacy and safety of parenteral iron dextran have been convincingly demonstrated, supplementation may be contraindicated in the setting of infection.
D L Burns, and
E A Mascioli, and
B R Bistrian
February 1990,
DICP : the annals of pharmacotherapy,
D L Burns, and
E A Mascioli, and
B R Bistrian
March 1999,
Kidney international. Supplement,
D L Burns, and
E A Mascioli, and
B R Bistrian
March 1960,
The Illinois medical journal,
D L Burns, and
E A Mascioli, and
B R Bistrian
May 2021,
American journal of hematology,
D L Burns, and
E A Mascioli, and
B R Bistrian
November 1974,
The Journal of the Kentucky Medical Association,
D L Burns, and
E A Mascioli, and
B R Bistrian
July 1978,
Schweizer Archiv fur Tierheilkunde,
D L Burns, and
E A Mascioli, and
B R Bistrian
April 1985,
American journal of hospital pharmacy,
D L Burns, and
E A Mascioli, and
B R Bistrian
June 1969,
Kinderarztliche Praxis,
D L Burns, and
E A Mascioli, and
B R Bistrian
January 1989,
M.D. computing : computers in medical practice,
D L Burns, and
E A Mascioli, and
B R Bistrian
May 2008,
The Israel Medical Association journal : IMAJ,
